Journal
NEUROSCIENCE
Volume 417, Issue -, Pages 57-69Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2019.08.010
Keywords
Alzheimer's disease; Young blood serum; Memory; Cholinergic transmission
Categories
Funding
- Hei Long Jiang Postdoctoral Foundation [LBH-Z17170]
- Innovative Scientific Research Funding Project of Harbin Medical University [2017JCZX34]
- Fundamental Research Funds for the Provincial Universities [2017-KYYWF-0338]
- Scientific Research Project of Health Commission of Heilongjiang Province [2018468]
- Heilongjiang Provincial Natural Science Foundation of China [LH2019H068]
Ask authors/readers for more resources
An increasing number of studies have demonstrated the benefits of young individual-derived blood for aging-related diseases. However, the effects of young blood on the cognitive and cholinergic transmission defects in aging-associated Alzheimer's disease (AD) remain elusive. In the current study, we showed that young blood serum delivered intravenously attenuated deficits in hippocampal-dependent learning and memory, alleviated hippocampal Ab plaque pathology, restored synapse formation and synaptic plasticity, repaired the hippocampal cholinergic circuit, and triggered several canonical neuroprotective mechanisms [including repressor element 1-silencing transcription factor (REST)/Forkhead box protein O1 (FOXO1) signaling] in aged AD model mice. However, pharmacological blockage of hippocampal cholinergic activity nearly abrogated the neuroprotective actions of young blood serum in AD mice. Thus, our findings suggest that exogenous young blood serum exerts therapeutic effects on AD-associated cognitive disorders and pathology by promoting hippocampal cholinergic input and simultaneously activating other neuroprotective mechanisms. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available